Recombinant Human IFNG Protein, MYC/DDK-tagged
| Cat.No. : | IFNG-1184H |
| Product Overview : | Recombinant human IFNG protein, fused to MYC/DDK tag at C-terminus, was expressed in HEK293. |
- Specification
- Gene Information
- Related Products
| Description : | Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. [UniProtKB/Swiss-Prot Function] |
| Source : | HEK293 |
| Species : | Human |
| Tag : | MYC/DDK |
| Form : | 25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10 % glycerol. |
| Molecular Mass : | 16.7 kDa |
| Purity : | >50 ug/mL as determined by microplate BCA method |
| Concentration : | >50 ug/mL as determined by microplate BCA method |
| Gene Name : | IFNG interferon, gamma [ Homo sapiens ] |
| Official Symbol : | IFNG |
| Synonyms : | IFG; IFI |
| Gene ID : | 3458 |
| mRNA Refseq : | NM_000619 |
| Protein Refseq : | NP_000610 |
| MIM : | 147570 |
| UniProt ID : | P01579 |
Products Types
| ◆ Recombinant Protein | ||
| Ifng-379I | Active Recombinant Mouse Ifng Protein (134 aa) | +Inquiry |
| IFNG-4340F | Recombinant Ferret IFNG Protein | +Inquiry |
| IFNG-264I | Active Recombinant Human IFNG Protein | +Inquiry |
| IFNG-105I | Active Recombinant Human IFNG Protein (144 aa) | +Inquiry |
| IFNG-8549H | Active Recombinant Human IFNG protein(Met1-Gln166) | +Inquiry |
| ◆ Lysates | ||
| IFNG-1797MCL | Recombinant Mouse IFNG cell lysate | +Inquiry |
| IFNG-1536RCL | Recombinant Rat IFNG cell lysate | +Inquiry |
| IFNG-001HCL | Recombinant Human IFNG cell lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
0
Inquiry Basket
